Different treatment outcomes with different formulations of clobetasol propionate 0.05% for the treatment of plaque psoriasis.

S, Mraz; C, Leonardi; LE, Colón; LA, Johnson

doi:10.1080/09546630802449104

Public

Different treatment outcomes with different formulations of clobetasol propionate 0.05% for the treatment of plaque psoriasis.

Shared by NobleBlocks on Jan 1, 2008 • 12:00 AM UTC

Authors:

Mraz S

Leonardi C

Colón LE

Abstract

Two advanced formulations of clobetasol propionate (CP) 0.05% (Clobex Spray; Galderma Laboratories, L.P., Fort Worth, TX, USA and Olux Foam; Stiefel/Connetics Corp., Coral Gables, FL, USA) were compared in a study of 77 randomized patients with moderate to severe plaque psoriasis. At the end of the ...

Discussions